SLI
2.110,61
PKT
-29,71
PKT
-1,39
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 28.04.20 | Novartis buy | Jefferies & Company Inc. | |
| 28.04.20 | Nestlé Underperform | RBC Capital Markets | |
| 27.04.20 | Roche overweight | Morgan Stanley | |
| 27.04.20 | Nestlé buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.04.20 | Nestlé Hold | Jefferies & Company Inc. | |
| 27.04.20 | Nestlé Neutral | Credit Suisse Group | |
| 27.04.20 | Nestlé buy | Goldman Sachs Group Inc. | |
| 27.04.20 | UBS buy | UBS AG | |
| 27.04.20 | Swiss Re buy | Goldman Sachs Group Inc. | |
| 27.04.20 | Zurich Insurance buy | Goldman Sachs Group Inc. | |
| 27.04.20 | Nestlé overweight | Barclays Capital | |
| 27.04.20 | Holcim overweight | JP Morgan Chase & Co. | |
| 24.04.20 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 24.04.20 | Nestlé buy | UBS AG | |
| 24.04.20 | UBS Sector Perform | RBC Capital Markets | |
| 24.04.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 24.04.20 | Nestlé buy | Goldman Sachs Group Inc. | |
| 24.04.20 | UBS buy | Deutsche Bank AG | |
| 24.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.04.20 | UBS Neutral | JP Morgan Chase & Co. | |
| 23.04.20 | UBS Sector Perform | RBC Capital Markets | |
| 23.04.20 | Roche buy | UBS AG | |
| 23.04.20 | UBS buy | UBS AG | |
| 23.04.20 | UBS buy | Goldman Sachs Group Inc. | |
| 23.04.20 | UBS Neutral | JP Morgan Chase & Co. | |
| 23.04.20 | Nestlé overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Holcim buy | HSBC | |
| 23.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 23.04.20 | Roche Neutral | Credit Suisse Group | |
| 22.04.20 | Roche overweight | JP Morgan Chase & Co. | |
| 22.04.20 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. | |
| 22.04.20 | Roche Conviction Buy List | Goldman Sachs Group Inc. | |
| 22.04.20 | UBS buy | Goldman Sachs Group Inc. | |
| 22.04.20 | UBS buy | Goldman Sachs Group Inc. | |
| 22.04.20 | Roche buy | Jefferies & Company Inc. | |
| 22.04.20 | UBS buy | HSBC | |
| 22.04.20 | Givaudan Underweight | Barclays Capital | |
| 22.04.20 | UBS Hold | HSBC | |
| 20.04.20 | Givaudan Neutral | JP Morgan Chase & Co. |